According to NantKwest 's latest financial reports the company's current revenue (TTM) is $0.11 M. In 2019 the company made a revenue of $0.04 M a decrease over the years 2018 revenue that were of $0.04 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2020 (TTM) | $0.11 M | 158.14% |
2019 | $0.04 M | -8.51% |
2018 | $0.04 M | 4.44% |
2017 | $0.04 M | 2.27% |
2016 | $0.04 M | -81.28% |
2015 | $0.23 M | -63.34% |
2014 | $0.64 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Ocular Therapeutix OCUL | $58.44 M | 52,550.45% | ๐บ๐ธ USA |
Oragenics OGEN | N/A | N/A | ๐บ๐ธ USA |
OncoCyte
OCX | -$2.37 M | -2,227.03% | ๐บ๐ธ USA |